Price
$251.47
Decreased by -5.01%
Dollar volume (20D)
239.90 M
ADR%
4.63
Earnings report date
May 7, 2025
Shares float
69.91 M
Shares short
2.40 M [3.43%]
Shares outstanding
70.23 M
Market cap
18.59 B
Beta
1.30
Price/earnings
45.80
20D range
236.70 276.13
50D range
230.05 289.46
200D range
173.00 289.46

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally.

The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface.

It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy.

The company sells its products to end-users through the pharmacy channel; and independent distributors.

Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
Feb 20, 25 1.15
Decreased by -17.86%
1.02
Increased by +12.63%
Nov 7, 24 0.90
Increased by +26.76%
0.76
Increased by +18.42%
Aug 8, 24 0.55
Increased by +44.74%
0.56
Decreased by -1.79%
May 9, 24 0.73
Increased by +217.39%
0.39
Increased by +87.18%
Feb 22, 24 1.40
Increased by +483.33%
0.66
Increased by +112.12%
Nov 2, 23 0.71
Increased by +102.86%
0.40
Increased by +77.50%
Aug 8, 23 0.38
Increased by +176.00%
0.26
Increased by +46.15%
May 4, 23 0.23
Decreased by -42.50%
0.11
Increased by +109.09%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Dec 31, 24 597.50 M
Increased by +17.20%
100.70 M
Decreased by -2.52%
Increased by +16.85%
Decreased by -16.83%
Sep 30, 24 372.60 M
Decreased by -13.89%
77.50 M
Increased by +49.33%
Increased by +20.80%
Increased by +73.41%
Jun 30, 24 488.50 M
Increased by +23.20%
188.60 M
Increased by +590.84%
Increased by +38.61%
Increased by +460.74%
Mar 31, 24 441.70 M
Increased by +23.35%
51.50 M
Increased by +116.39%
Increased by +11.66%
Increased by +75.43%
Dec 31, 23 509.80 M
Increased by +37.90%
103.30 M
Increased by +507.65%
Increased by +20.26%
Increased by +340.66%
Sep 30, 23 432.70 M
Increased by +26.97%
51.90 M
Increased by +1.10 K%
Increased by +11.99%
Increased by +886.10%
Jun 30, 23 396.50 M
Increased by +32.43%
27.30 M
Increased by +178.00%
Increased by +6.89%
Increased by +158.90%
Mar 31, 23 358.10 M
Increased by +21.23%
23.80 M
Decreased by -14.39%
Increased by +6.65%
Decreased by -29.38%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY